$1.27B
$64.3 Million
22.73% of portfolio
4,325,000
Q2 2022
Reduced 1.54%
$70.8B
$25.3 Million
8.95% of portfolio
225,000
Q2 2023
New
The Panagram Bbb B Clo ETF
-
$19.3 Million
6.82% of portfolio
-
Q4 2023
Added 494.36%
$1.12T
$17.1 Million
6.04% of portfolio
112,220
Q3 2022
Added 1,900.0%
-
$16.8 Million
5.95% of portfolio
-
Q1 2024
Reduced 41.18%
$1.42B
$8.41 Million
2.97% of portfolio
115,000
Q1 2022
Added 53.33%
$4.07B
$8.32 Million
2.94% of portfolio
101,436
Q1 2024
Reduced 62.55%
The Invesco Aaa Floating Rate Note ETF
-
$7.86 Million
2.78% of portfolio
-
Q4 2023
Added 296.78%
$312M
$7.78 Million
2.75% of portfolio
1,925,000
Q3 2023
Added 37.5%
$157B
$6.87 Million
2.43% of portfolio
247,537
Q1 2024
Added 153.79%
$0
$6.35 Million
2.24% of portfolio
125,079
Q1 2024
Added 33.56%
$1.15B
$6.02 Million
2.13% of portfolio
825,000
Q1 2024
Reduced 40.22%
-
$5.98 Million
2.12% of portfolio
-
Q1 2024
Added 1.56%
$852M
$5.62 Million
1.99% of portfolio
333,000
Q1 2024
Added 32.22%
$747M
$4.89 Million
1.73% of portfolio
473,597
Q1 2024
New
$179M
$4.32 Million
1.53% of portfolio
564,549
Q4 2023
Added 24.35%
$593B
$4.2 Million
1.49% of portfolio
20,985
Q1 2023
Added 2.94%
$291M
$4.08 Million
1.44% of portfolio
-
Q1 2024
New
$1.59B
$2.99 Million
1.06% of portfolio
187,852
Q1 2024
Added 49.74%
-
$2.79 Million
0.99% of portfolio
-
Q1 2023
Added 8.33%
$3.41B
$2.76 Million
0.97% of portfolio
85,300
Q1 2024
Added 5,644.11%
$70.3B
$2.6 Million
0.92% of portfolio
70,000
Q4 2022
New
$5.59B
$2.44 Million
0.86% of portfolio
100,000
Q1 2024
New
$999M
$2.4 Million
0.85% of portfolio
276,000
Q1 2024
New
-
$2.37 Million
0.84% of portfolio
-
Q4 2023
Added 494.35%
$4.89B
$2.33 Million
0.82% of portfolio
7,500
Q1 2024
New
$619M
$2.27 Million
0.8% of portfolio
83,557
Q1 2024
New
$122B
$2.19 Million
0.77% of portfolio
45,000
Q1 2024
Reduced 4.26%
$38B
$1.9 Million
0.67% of portfolio
95,000
Q2 2022
New
$881M
$1.85 Million
0.65% of portfolio
115,000
Q1 2024
Added 251.98%
$528M
$1.78 Million
0.63% of portfolio
230,966
Q1 2024
Added 4.51%
$3.29B
$1.7 Million
0.6% of portfolio
49,000
Q4 2023
Reduced 1.01%
$1.16B
$1.56 Million
0.55% of portfolio
65,475
Q1 2024
New
$0
$1.52 Million
0.54% of portfolio
16,000
Q1 2024
Added 433.33%
$1.7B
$1.52 Million
0.54% of portfolio
52,368
Q3 2023
New
$5.51B
$1.39 Million
0.49% of portfolio
12,000
Q3 2023
Reduced 3.23%
$306M
$1.33 Million
0.47% of portfolio
600,000
Q1 2024
Added 54.68%
$120B
$1.25 Million
0.44% of portfolio
3,000
Q2 2023
Reduced 57.14%
Syros Pharmaceutical, Inc
-
$1.25 Million
0.44% of portfolio
-
Q1 2024
Added 191.52%
$609M
$1.12 Million
0.4% of portfolio
80,000
Q1 2024
Added 9.49%
$321M
$1.04 Million
0.37% of portfolio
140,000
Q1 2024
New
$2.43B
$1.03 Million
0.36% of portfolio
23,866
Q2 2023
Reduced 40.34%
$89.7B
$980,000
0.35% of portfolio
14,000
Q4 2023
New
$4.79B
$957,000
0.34% of portfolio
3,584
Q1 2024
Reduced 75.78%
$303B
$917,000
0.32% of portfolio
5,037
Q4 2022
Reduced 74.86%
$46.6B
$776,000
0.27% of portfolio
6,000
Q4 2021
New
$40.3B
$761,000
0.27% of portfolio
9,930
Q1 2023
Reduced 10.83%
$3.33T
$673,000
0.24% of portfolio
1,600
Q2 2022
Added 14.29%
$38.8B
$667,000
0.24% of portfolio
11,563
Q4 2021
New
$37.3B
$645,000
0.23% of portfolio
11,136
Q1 2022
Reduced 4.4%